Teva Emerges From Restructuring Ready To Grow

Captures 12%-15% Rituximab Share In US With Truxima Biosimilar

Butterfly
Teva has emerged from years of restructuring ready to grow • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business